BAYER AND ARVINAS UNVEIL TARGETED PROTEIN DEGRADATION JOINT VENTURE, OERTH BIO – Oerth Bio to utilize Arvinas’ PROTAC® technology to develop innovative new agricultural products to improve crop yields – John Dombrosky Announced as CEO of Oerth Bio –...
ARVINAS STRENGTHENS SCIENTIFIC ADVISORY BOARD WITH LEADERS IN ONCOLOGY AND NEUROLOGICAL DISORDERS NEW HAVEN, Conn., Oct. 02, 2019 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on targeted protein...
Three Recent Preclinical Publications Highlight NMDA Receptor Activation Facilitated by Aptinyx’s NYX-2925 Data published across three peer-reviewed journals elucidate novel mechanism leading to enhanced synaptic plasticity EVANSTON, Ill., Sept. 26, 2019 (GLOBE...
Bozeman Health Engages Kyruus to Support its Digital Transformation and Integrate Patient Access System-wide Montana-Based Health System to Enhance Access and Convenience for Rising Patient Population with Kyruus ProviderMatch® Boston, MA – October 15, 2019 – Kyruus,...
Lafayette General Health to Elevate Consumer Digital Experience and Launch Online Scheduling with Kyruus Louisiana-Based Health System Looking to Simplify Patient Access and Enhance Patient-Provider Matching for Growing Population Boston, MA – October 7,...
Recent Comments